Join us at GISE 2025
Milano, MiCo, Oct 1-4
Attend the two symposia, diving into the latest innovations and the modern era of expanding indications. Explore our insightful activities at the booth and join the Lifetime Management Pathway at our Training Village.
Friday 3 October
Edwards Training Village - Corner E
Booth 28 Exhibition Area
Friday 3 October
Early or Earlier? A paradigm shift in the Aortic Stenosis disease
Friday October 3rd | 13:05-14:05
Room Amber 3-4
Add to calendarModerators: C. Gandolfo, P. Golino, I. Porto
What is the effect of sAS on the heart and does this influence outcomes?
G. Pesarini
From Evidence to Guidelines: what we can agree and what remains controversial
D. Capodanno
Traditional thinking and new perspectives on the ‘modern era’ of sAS management
M. Barbanti
Strategic capacity planning for raising patients care: Is there a price for the patients waiting for Symptoms?
F. Saia
Conclusions
Redefining Possibilities in Mitral and Tricuspid Valve Care
Friday October 3rd | 14:15-14:45
Room Amber 3-4
Add to calendarModerator: F. De Marco
Welcome and introduction
F. De Marco
TR cases: Repair or Replacement, this is the question
M. Adamo
MR cases: Repair or Replacement, this is the question
F. Bedogni
Discussion
Edwards Training Village - Corner E
Hands-On Lifetime Management tutorials and whispering sessions with Leading Experts
Thursday October 2nd | 16:30-17:15
Mastering future reinterventions with SAPIEN Platform: Avoiding pitfalls, planning for redo
L. Nai Fovino, Padova
Friday October 3rd | 15:00-15:45
Long-Term Success starts with SAPIEN Platform: Built for excellent performance
R. Vergallo, Genova
Booth 28 Exhibition Area
Join us at our Booth 28 Exhibition Area
Thursday October 2nd | 12:00 – 12:45
The Edwards Benchmark practices and the CVC role in the modern era of expanding indications and the growing need for SAS treatment
F. Meucci, Firenze
B. Hamiti, Firenze
F. Germinal, Lecce
Friday October 3rd | 16:45 – 17:30
Using the Edwards Benchmark Economics Results to unlock hospital capacity and access to innovation
L. Vignali, Parma
P. Colombo, Milano
Download our literature to learn more about our therapies
To receive a summary of our GISE 2025 activities, recordings, slide decks and future developments, join the Edwards Lifesciences community today.
heading 3
Content goes here
Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).
No clinical data are available to evaluate the long-term impact of RESILIA tissue in patients. Additional clinical data for up to 10 years of follow-up are being collected to monitor the long-term safety and performance of RESILIA tissue.